TerminatedPhase 4NCT01302444

Treprostinil Combined With Tadalafil for Pulmonary Hypertension

Studying Drug- or toxin-induced pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rhode Island Hospital
Principal Investigator
James R Klinger, MD
Rhode Island Hospital
Intervention
Tadalafil(drug)
Enrollment
1 enrolled
Eligibility
18-80 years · All sexes
Timeline
20112012

Study locations (9)

Collaborators

United Therapeutics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01302444 on ClinicalTrials.gov

Other trials for Drug- or toxin-induced pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Drug- or toxin-induced pulmonary arterial hypertension

← Back to all trials